BCAT1 and lung carcinoma: BCAT1 can enhance BCAA metabolism, thereby increasing mitochondrial respiration and biosynthesis, reducing reactive oxygen species (ROS) levels, and ultimately enhancing NF-κB pathway signaling (Yu et al., 2022), promoting lung cancer development.